Cargando…
CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
Metastatic renal cell carcinoma (mRCC) is nearly incurable and accounts for most of the mortality associated with RCC. Von Hippel Lindau (VHL) is a tumour suppressor that is lost in the majority of clear cell RCC (ccRCC) cases. Its role in regulating hypoxia-inducible factors-1α (HIF-1α) and -2α (HI...
Autores principales: | Schokrpur, Shiruyeh, Hu, Junhui, Moughon, Diana L., Liu, Peijun, Lin, Lucia C., Hermann, Kip, Mangul, Serghei, Guan, Wei, Pellegrini, Matteo, Xu, Hua, Wu, Lily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928183/ https://www.ncbi.nlm.nih.gov/pubmed/27358011 http://dx.doi.org/10.1038/srep29032 |
Ejemplares similares
-
A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model
por: Hu, Junhui, et al.
Publicado: (2018) -
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023) -
The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons
por: Minovitsky, Simon, et al.
Publicado: (2005) -
VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2023) -
In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens
por: Chow, Ryan D., et al.
Publicado: (2019)